Aardvark Therapeutics【AARD】銘柄情報

Aardvark Therapeutics Inc (AARD) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

3.79

( -1.30% )

買値

3.35

売値

4.00

出来高

803

0.00 日の範囲 0.00

3.35 52 週間の範囲 17.94

時価総額

82.684M

前日終値

3.84

始値

時刻

3.99

最終取引時間

19:06:13

財務取引量

VWAP

平均取引量 (3 か月)

US$ 192,673

発行済株式数

21,816,385

配当利回り

PER

-1.22

1 株当たり利益 (EPS)

-3.21

歳入

純利益

-69.87M

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, Californ... Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

aardvarktherapeutics.com

本社

San Diego, United States

設立

2026

Aardvark Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker AARD. The last closing price for Aardvark Therapeutics was US$3.84. Over the last year, Aardvark Therapeutics shares have traded in a share price range of US$ 3.35 to US$ 17.94.

Aardvark Therapeutics currently has 21,816,385 shares in issue. The market capitalisation of Aardvark Therapeutics is US$82.68 million. Aardvark Therapeutics has a price to earnings ratio (PE ratio) of -1.22.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.2	5.57103064067	3.59	4.1	3.4	128890	3.72021122	CS
4	-0.53	-12.2685185185	4.32	4.8	3.4	145840	4.01277573	CS
12	-0.01	-0.263157894737	3.8	6.79	3.35	177983	4.50290283	CS
26	-10.61	-73.6805555556	14.4	16.6	3.35	218520	7.30080458	CS
52	-7.17	-65.4197080292	10.96	17.94	3.35	181576	9.03726153	CS
156	-9.6	-71.6952949963	13.39	19.58	3.35	160832	9.25492961	CS
260	-9.6	-71.6952949963	13.39	19.58	3.35	160832	9.25492961	CS